Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1978 Mar;45(3):378-84.
doi: 10.1016/0030-4220(78)90523-6.

A randomized double-blind trial of levamisole in the therapy of recurrent aphthous stomatitis

J De Cree, H Verhaegen, W De Cock, F Verbruggen
Clinical Trial

A randomized double-blind trial of levamisole in the therapy of recurrent aphthous stomatitis

J De Cree et al. Oral Surg Oral Med Oral Pathol. 1978 Mar.

Abstract

A Controlled, double-blind study was performed to compare the effects of levamisole and placebo in eighteen patients with recurrent aphthous stomatitis. Levamisole is a drug which enhances defective cellular immune responses. It was administered in a flexible dosage schedule: 50 mg. three times daily for three consecutive days at the start of an aphthous lesion but with an interval of at least 2 weeks between courses of therapy. Placebo consisted of pills that were identical in appearance, taken according to the same schedule. Statistical evaluation showed decreased frequency of lesions, shorter duration, and diminished pain of lesions in the group receiving levamisole. Subsequent follow-up in an open trial confirmed these results.

PubMed Disclaimer